SYL-116021

N/A

Report date: 2025/01/26 17:23:51
NME

Base Information

Drug NameSYL-116021
Drug Alias NamesiRNA targeting PDK1 gene (Sylentis)PDK1 siRNA (Sylentis)SYL-116021
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSylentis Sa
China Registration ClassN/A

Develop Information

Active CompaniesSylentis Sa
Inactive CompaniesN/A
Active IndicationsConjunctivitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A